First-In-Human Study of Bispecific Antibody MR001 In Subjects With Advanced Solid Tumors
Clinical trial NCT06134531 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06134531
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2026-07-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.